Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial [NA]
The PRECISE trial is investigating a tailored, supervised, remote exercise program to improve physical function in Stage I-III gastroesophag…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients [NA]
A recruiting clinical trial evaluating high-flow nasal cannula to prevent hypoxia during sedated endoscopy in high-risk obstructive sleep ap…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Surgery for Obstructed Gastric Carcinoma [NA]
A clinical trial sponsored by Zagazig University is evaluating surgery for obstructed gastric carcinoma; the study is currently active but n…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
A prospective study assessing gastric cancer screening using fecal multi-target DNA analysis, currently RECRUITING.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, and preliminary efficacy of XH001 injection combined with a neoantigen vacc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial [NA]
This clinical trial evaluates whether eradicating Helicobacter pylori subtypes reduces gastric cancer risk in high-risk individuals using a …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection
The document reports a prospective gastric cancer screening trial that uses detection of Helicobacter pylori high-risk SNPs, and it is curre…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
This is an observational clinical trial from Fudan University studying gastric cancer in people with high-risk Helicobacter pylori infection…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) [Phase 2]
Phase 2 clinical trial update on Givastomig combined with nivolumab and chemotherapy for CLDN18.2-positive metastatic gastric cancer; the st…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of AZD5863 in adults with advanced or metastatic solid tumors is currently recruiting, including gastric cancer, gastroeso…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Q702, an oral Axl/Mer/CSF1R tyrosine kinase inhibitor, in combination with pembrolizumab, for selected advanced…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Completed clinical trial evaluating frailty scales to predict chemotherapy toxicity in older adults with gastrointestinal cancers.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]
Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes [NA]
Cedars-Sinai Medical Center is recruiting for a study evaluating virtual reality to manage gastrointestinal cancer pain and improve patient-…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
AZD5305 is being evaluated as a monotherapy and in combination with anti-cancer agents in a Phase 1/2 trial for multiple advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination [Phase 1, Phase 2]
Phase 1/2 trial update evaluating MCLA-129, a bispecific anti-EGFR and anti-c-MET antibody, in advanced non-small cell lung cancer and other…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression [Phase 3]
Phase 3 trial evaluating bemarituzumab plus chemotherapy versus placebo plus chemotherapy in FGFR2b-overexpressing gastric and gastroesophag…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment [NA]
Clinical trial update on molecular analysis for gastro-esophageal cancer using a multicenter discrete choice experiment; the study is curren…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of MRG007 (ARR-217) in patients with advanced solid tumors is recruiting, evaluating safety and initial efficacy signals in …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Molecular Assessment for Gastro-Esophageal Cancer [NA]
A molecular assessment trial for gastro-esophageal cancers is currently recruiting at KU Leuven. The study encompasses Esophageal cancer, Ga…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 [Phase 4]
A Phase 4 clinical trial is evaluating Helicobacter pylori screening and treatment in an at-risk South Florida community. The study is curre…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients [NA]
This clinical trial update describes a study evaluating the effectiveness of managing chemotherapy side effects using electronic patient-rep…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 [Phase 2]
Phase 2 clinical trial evaluating AZD0901 in advanced solid tumours expressing Claudin18.2 is currently recruiting, including gastric cancer…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer [Phase 2]
This document provides an update on an ongoing Phase 1b/2 clinical trial evaluating SHR-A1811 combinations in advanced HER2-expressing gastr…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
This clinical trial update announces ongoing recruitment for a study of trastuzumab deruxtecan in adults with HER2-positive advanced gastric…